Bob's expertise and research focus lies within the field of parasite cell and molecular biology, as well as proteomics and population dynamics of malaria transmission. His research has an overall focus on discovery and characterisation of transmission-blocking vaccine candidates.
Sinden RE, 2017, Developing transmission-blocking strategies for malaria control, Plos Pathogens, Vol:13, ISSN:1553-7366
et al., 2017, A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance, Nature Communications, Vol:8, ISSN:2041-1723
et al., 2017, Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen, Nature Communications, Vol:8, ISSN:2041-1723
et al., 2017, Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery, Nanomedicine-nanotechnology Biology and Medicine, Vol:13, ISSN:1549-9634, Pages:515-525
et al., 2017, ACCELERATING THE DISCOVERY OF TRANSMISSION-BLOCKING DRUGS: HT SCREENING WITH A NOVEL PLASMODIUM FALCIPARUM FUNCTIONAL GAMETOCYTE ASSAY, 65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH), AMER SOC TROP MED & HYGIENE, Pages:82-82, ISSN:0002-9637